Udvalget for Humanmedicinske Lægemidler (CHMP) besluttede, at fordelene ved Levitra er større end risiciene ved behandling af erektil dysfunktion hos mænd.
The Committee for Medicinal Products for Human Use (CHMP) decided that Levitra’ s benefits are greater than its risks for the treatment of men with erectile dysfunction.